Literature DB >> 23939642

A primary care approach to substance misuse.

Brad Shapiro1, Diana Coffa, Elinore F McCance-Katz.   

Abstract

Substance misuse is common among patients in primary care settings. Although it has a substantial health impact, physicians report low levels of preparedness to identify and assist patients with substance use disorders. An effective approach to office-based treatment includes a coherent framework for identifying and managing substance use disorders and specific strategies to promote behavior change. Brief validated screening tools allow rapid and efficient identification of problematic drug use, including prescription medication misuse. After a positive screening, a brief assessment should be performed to stratify patients into three categories: hazardous use, substance abuse, or substance dependence. Patients with hazardous use benefit from brief counseling by a physician. For patients with substance abuse, brief counseling is also indicated, with the addition of more intensive ongoing follow-up and reevaluation. In patients with substance dependence, best practices include a combination of counseling, referral to specialty treatment, and pharmacotherapy (e.g., drug tapering, naltrexone, buprenorphine, methadone). Comorbid mental illness and intimate partner violence are common in patients with substance use disorders. The use of a motivational rather than a confrontational communication style during screening, counseling, and treatment is important to improve patient outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 23939642

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  24 in total

1.  Ethical Issues Arising from Marijuana Use by Nursing Mothers in a Changing Legal and Cultural Context.

Authors:  Jessica Miller
Journal:  HEC Forum       Date:  2019-03

2.  Family Physicians' Perceived Prevalence, Safety, and Screening for Cigarettes, Marijuana, and Electronic-Nicotine Delivery Systems (ENDS) Use during Pregnancy.

Authors:  Thomas F Northrup; Michelle R Klawans; Yolanda R Villarreal; Adi Abramovici; Melissa A Suter; Joan M Mastrobattista; Carlos A Moreno; Kjersti M Aagaard; Angela L Stotts
Journal:  J Am Board Fam Med       Date:  2017 Nov-Dec       Impact factor: 2.657

3.  Medicines containing codeine: perspectives of medical professionals in the Republic of Ireland.

Authors:  M Foley; T Carney; R Harris; E Fitzpatrick; A Rapca-Veillet; M C Van Hout
Journal:  Ir J Med Sci       Date:  2017-01-09       Impact factor: 1.568

4.  DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.

Authors:  Li-Tzy Wu; Jennifer McNeely; Geetha A Subramaniam; Kathleen T Brady; Gaurav Sharma; Paul VanVeldhuisen; He Zhu; Robert P Schwartz
Journal:  Drug Alcohol Depend       Date:  2017-07-13       Impact factor: 4.492

5.  Physicians' experiences of SBIRT training and implementation for SUD management in primary care in the UAE: a qualitative study.

Authors:  Christiane Pflanz-Sinclair; Catriona Matheson; Christine M Bond; Amna Almarzouqi; Amanda J Lee; Anwar Batieha; Hamad Al Ghaferi; Ahmed El Kashef
Journal:  Prim Health Care Res Dev       Date:  2017-12-26       Impact factor: 1.458

Review 6.  Overcoming Barriers to Integrating Behavioral Health and Primary Care Services.

Authors:  Kyle L Grazier; Mary L Smiley; Kirsten S Bondalapati
Journal:  J Prim Care Community Health       Date:  2016-07-04

7.  Prevalence of Substance Use Among Patients of Community Health Centers in East Los Angeles and Tijuana.

Authors:  Lillian Gelberg; Guillermina Natera Rey; Ronald M Andersen; Miriam Arroyo; Ietza Bojorquez-Chapela; Melvin W Rico; Mani Vahidi; Julia Yacenda-Murphy; Lisa Arangua; Martin Serota
Journal:  Subst Use Misuse       Date:  2016-12-21       Impact factor: 2.164

8.  Transitioning From Detoxification to Substance Use Disorder Treatment: Facilitators and Barriers.

Authors:  Christine Timko; Nicole R Schultz; Jessica Britt; Michael A Cucciare
Journal:  J Subst Abuse Treat       Date:  2016-07-29

9.  Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool.

Authors:  Li-Tzy Wu; Jennifer McNeely; Geetha A Subramaniam; Gaurav Sharma; Paul VanVeldhuisen; Robert P Schwartz
Journal:  Contemp Clin Trials       Date:  2016-07-19       Impact factor: 2.226

10.  Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment?

Authors:  Kenneth Blum; Mark Gold; H Westley Clark; Kristina Dushaj; Rajendra D Badgaiyan
Journal:  Subst Use Misuse       Date:  2016-07-27       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.